Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VELA TECHNOLOGIES PLC Director's Dealing 2018

Jun 12, 2018

8002_mrq_2018-06-12_266fcb66-cca4-40ff-bad2-0373b75fa413.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1753R

Vela Technologies PLC

12 June 2018

12 June 2018

Vela Technologies plc

("Vela" or the "Company")

Holdings in Company

The Board of Vela announces that the Company was notified on 8 June 2018 that Scott Fletcher's interest in the share capital of the Company remains unchanged at 63,944,656 ordinary shares and, following the completion of the Company's placing in December 2017, his percentage interest has fallen from 8.86% to 7.64%.

In addition, the Company was notified on 7 June 2018 that Kevin Sinclair's interest in the share capital of the Company remains unchanged at 106,449,000 ordinary shares and, following the completion of the Company's placing in December 2017, his percentage interest has fallen from 14.75% to 12.72%.

For further information, please contact:

Vela Technologies plc
Brent Fitzpatrick, Non-Executive Chairman

Antony Laiker, Director
Tel: +44 (0) 7802 262 443
Allenby Capital Limited

(Nominated Adviser)

Nick Athanas/Asha Chotai
Tel: +44 (0) 20 3328 5656
Smaller Company Capital Limited

(Broker)

Rupert Williams/Jeremy Woodgate
Tel: +44 (0) 20 3651 2910

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

HOLGGUBAQUPRGAP